scispace - formally typeset
G

Ge Gao

Researcher at Pohang University of Science and Technology

Publications -  34
Citations -  2043

Ge Gao is an academic researcher from Pohang University of Science and Technology. The author has contributed to research in topics: 3D bioprinting & Medicine. The author has an hindex of 13, co-authored 27 publications receiving 1187 citations. Previous affiliations of Ge Gao include Beijing Institute of Technology.

Papers
More filters
Journal ArticleDOI

3D cell printing of in vitro stabilized skin model and in vivo pre-vascularized skin patch using tissue-specific extracellular matrix bioink: A step towards advanced skin tissue engineering

TL;DR: This study investigated the capability of skin-derived extracellular matrix (S-dECM) bioink for 3D cell printing-based skin tissue engineering and used this bioink to print 3D pre-vascularized skin patch able to promote in vivo wound healing and revealed that endothelial progenitor cells-laden 3D-printed skin patch accelerates wound closure, re-epithelization, and neovascularization as well as blood flow.
Journal ArticleDOI

Direct 3D cell-printing of human skin with functional transwell system

TL;DR: A hybrid 3D cell-printing system was developed, allowing for the use of extrusion and inkjet modules at the same time, and it was observed that a 50 times reduction in cost was achieved and 10 times less medium was used than in a conventional culture.
Journal ArticleDOI

A 3D cell printed muscle construct with tissue-derived bioink for the treatment of volumetric muscle loss.

TL;DR: It is suggested that a 3D cell printing and tissue-derived bioink-based approach could effectively generate biomimetic engineered muscles to improve the treatment of VML injuries.
Journal ArticleDOI

Biomaterials-based 3D cell printing for next-generation therapeutics and diagnostics.

TL;DR: This review gives an overview of recent developments in 3D cell printing and bioinks and provides technical requirements for engineering human tissues and proposes suggestions on the development of next-generation therapeutics and diagnostics.